Literature DB >> 27743880

Haemodialysis alters peripheral nerve morphology in end-stage kidney disease.

Adeniyi A Borire1, Ria Arnold2, Bruce A Pussell1, Natalie C Kwai1, Leo H Visser3, Luca Padua4, Neil G Simon5, Matthew C Kiernan6, Arun V Krishnan7.   

Abstract

OBJECTIVE: We explored the nerve ultrasound (US) characteristics of 15 patients with end-stage kidney disease (ESKD) and correlated these findings with clinical severity and electrophysiological parameters of neuropathy.
METHODS: 15 ESKD patients on thrice-weekly high-flux haemodialysis and 15 healthy controls were enrolled. Sonographic and electrophysiologic studies were conducted before and after a single session of haemodialysis. Serial measurements of median nerve cross-sectional area (CSA) and hypoechoic fraction (HF) were performed at the same non-entrapment site in the mid-forearm. Neuropathy severity was quantified using the total neuropathy score (TNS).
RESULTS: 86.7% of the ESKD cohort had neuropathy (TNS>1). ESKD patients had significantly higher baseline CSA (8.9±1.2mm2 vs 7.5±1.0mm2, p<0.05) and HF (56.0±1.0% vs 54.0±1.1%, p<0.05) compared with the control group. The CSA correlated significantly with TNS (r=0.826; p<0.0001) and other electrophysiological parameters. There was a reduction in both the CSA (8.3±1.4mm2; p<0.01) and HF (55.0±1.6%; p<0.05) after a single session of HD. A significant relationship was also found between the change in CSA and change in serum K+ after dialysis (r=0.782, p<0.01).
CONCLUSIONS: This study shows that peripheral nerves in ESKD patients are larger and more hypoechoic and that these morphological abnormalities may be reversed by dialysis. SIGNIFICANCE: US may be useful as an early marker of neuropathy in ESKD.
Copyright © 2016 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cross-sectional area; End stage kidney disease; Hypoechoic fraction; Nerve ultrasound; Neuropathy; Total neuropathy score

Mesh:

Year:  2016        PMID: 27743880     DOI: 10.1016/j.clinph.2016.09.010

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  5 in total

Review 1.  Current and Emerging Pharmacotherapeutic Interventions for the Treatment of Peripheral Nerve Disorders.

Authors:  Jeremy Chung Bo Chiang; Ria Arnold; Roshan Dhanapalaratnam; Maria Markoulli; Arun V Krishnan
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-15

2.  Chronic kidney disease and peripheral nerve function in the Health, Aging and Body Composition Study.

Authors:  Ranjani N Moorthi; Simit Doshi; Linda F Fried; Sharon M Moe; Mark J Sarnak; Suzanne Satterfield; Ann V Schwartz; Michael Shlipak; Brittney S Lange-Maia; Tamara B Harris; Anne B Newman; Elsa S Strotmeyer
Journal:  Nephrol Dial Transplant       Date:  2019-04-01       Impact factor: 5.992

3.  Clinical and ultrasonographic screening for carpal tunnel syndrome in hemodialysis patients.

Authors:  Samar Tharwat; Mohammed Kamal Nassar
Journal:  Kidney Res Clin Pract       Date:  2020-06-30

4.  Shear Wave Elastography in the Diagnosis of Peripheral Neuropathy in Patients With Chronic Kidney Disease Stage 5.

Authors:  Xuan Li; Haoqi Sun; Zhaoguang Zhang; Jing Liu; Huiying Xu; Lin Ma; Haibo Zhang; Jialin Li; Qian Luo; Xiangming Wang; Min Guo; Zhentao Guo; Xuexun Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

5.  Peripheral nerve morphology and intraneural blood flow in chronic kidney disease with and without diabetes.

Authors:  Tushar Issar; Susan Walker; Ria Arnold; Ann M Poynten; Zoltan H Endre; Arun V Krishnan
Journal:  Muscle Nerve       Date:  2022-02-23       Impact factor: 3.852

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.